Biomedical Research Business Architecture Model: Report and Analyze Study
From CTMS_WIKI
Contents |
Report and Analyze Study - Definition
The Report and Analyze Study aspect of the Biomedical Research Business Architecture Model effort underway in the Clinical Trials Management Systems Workspace of caBIG® is focused on the processes and activities that involve developing and providing an organized collection of information to authorized stakeholders in support of execution of the protocol statistical plan, subject safety and regulatory requirements.
See our Vision and Scope Document for more information about the Business Architecture Model (BAM).
Report and Analyze Study Working Groups
Report and Analyze Study working groups are comprised primarily of members from the Reporting and Sharing Special Interest Group in the CTMS Workspace; but we welcome volunteers from any CTMS Workspace Special Interest Group and the clinical research community.
If you would like to learn more about the plan study working activities, or find out how to join, please contact: Michele Ehlman: ehlmanmr@mail.nih.gov.
Working Group Topics and Materials:
Meetings & Communications
Report and Analyze Study Working Group Calls
The Report and Analyze Study Working Group schedule is:
Safety and Regulatory Working Group
- Work Group Lead and Co-Chair - Dr. John Ellerton
- Friday's at 11:00 AM EST - 12:30 PM EST
- Dial in Information 1-877-694-5747 pass code 4067767
- Centra
- URL: http://prod1.centra.com/main/Customers/ncicbEvent
- ID: RS_SafeReg
- Event Password: none
Adminstrative Reports Working Group
- Work Group Lead and Co-Chair - Tad McKeon
- Friday's at 1:00 PM EST - 2:00 PM EST
- Dial in Information 1-877-694-5747 pass code 4067767
- Centra
- URL: http://prod1.centra.com/main/Customers/ncicbEvent
- ID: RS_WGEvent
- Password: none
Calendar
For a calendar of all CTMS Workspace and Business Architecture Modeling working group meetings, Calendar
Submit Feedback
Please submit feedback, comments, and questions about the business modeling activities though the Clinical Trials Management Systems (CTMS) General discussions forum.
